Incyte Corp (INCY)

NASDAQ · Biotechnology

127.62
+4.15 (+3.36%)
Updated Aug 19, 5:47 PM ET
AI Rating
Buy
Overall Score
66
Trend
75
Momentum
57
Risk
66

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 122 sessions Aug 18, 2026

AI Analysis

Incyte Corp is trading at $127.62, up 3.36% on the session. The 50 day average sits at $114.71 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 60.3, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $115.77 with resistance near $124.57, so that band frames the current range. Average daily movement is roughly $3.59, or about 2.8% of the share price, which is what any stop placement has to allow for. The overall health score of 66 out of 100 combines a trend score of 75, momentum of 57 and a risk score of 66.

Technical indicators

RSI (14)
60.3
strong
MACD
2.018
bearish crossover
SMA 20
120.87
SMA 50
114.71
SMA 200
--
unknown
ATR (14)
3.59
avg daily range
Support
115.77
Resistance
124.57
Volume vs 20d
0.57x
below average
Volatility
40.5%
annualised
1 month
+6.76%
3 months
+29.71%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.